494 related articles for article (PubMed ID: 9149)
1. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
Barber AJ
Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
[TBL] [Abstract][Full Text] [Related]
2. Effect of lysolecithin of guanylate and adenylate cyclase activities in neuroblastoma cells in culture.
Zwiller J; Ciesielski-Treska J; Mandel P
FEBS Lett; 1976 Oct; 69(1):286-90. PubMed ID: 11126
[No Abstract] [Full Text] [Related]
3. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
4. Effects of Ca2+ and calmodulin on cyclic nucleotide metabolism in neurosecretosomes isolated from ox neurohypophyses.
Dartt DA; Torp-Pedersen C; Thorn NA
Brain Res; 1981 Jan; 204(1):121-8. PubMed ID: 6113872
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localizations of guanylate cyclase and 3',5'-cyclic nucleotide phosphodiesterase in sea urchin sperm.
Sano M
Biochim Biophys Acta; 1976 Apr; 428(2):525-31. PubMed ID: 6049
[TBL] [Abstract][Full Text] [Related]
6. The effect of adenylate cyclase inhibitor (ACI) on guanylate cyclase, phosphodiesterase and other enzymes in heart.
Lehotay DC; Levey GS; Vesely DL; Bornet EP; Ray MV; Entman ML; Schwartz A
J Cyclic Nucleotide Res; 1977 Feb; 3(1):55-65. PubMed ID: 14979
[TBL] [Abstract][Full Text] [Related]
7. Studies on cyclic adenosine 3' ,5'-monophosphate levels, Adenylate cyclase and phosphodiesterase activities in the dimorphic fungus Mucor rouxii.
Paveto C; Epstein A; Passeron S
Arch Biochem Biophys; 1975 Aug; 169(2):449-57. PubMed ID: 170864
[No Abstract] [Full Text] [Related]
8. Adenylate cyclase, guanylate cyclase and cyclic nucleotide phosphodiesterases of guinea-pig cardiac sarcolemma.
St Louis PJ; Sulakhe PV
Biochem J; 1976 Sep; 158(3):535-41. PubMed ID: 10895
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
10. Particulate guanylate cyclase and adenylate cyclase activities after activation with various agents in rabbit platelets. An ultracytochemical study.
Spreca A; Rambotti MG; Donato R
Histochem J; 1991 Mar; 23(3):143-8. PubMed ID: 1686024
[TBL] [Abstract][Full Text] [Related]
11. Adenyl cyclase and cyclic nucleotide phosphodiesterase activities in murine muscular dystrophy.
Lin CH; Hudson AJ; Strickland KP
Enzyme; 1976; 21(1):85-95. PubMed ID: 172329
[TBL] [Abstract][Full Text] [Related]
12. Adenylate cyclase and cyclic AMP phosphodiesterase in Bradyrhizobium japonicum bacteroids.
Catanese CA; Emerich DW; Zahler WL
J Bacteriol; 1989 Sep; 171(9):4531-6. PubMed ID: 2548992
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
Brüne B; Ullrich V
Mol Pharmacol; 1987 Oct; 32(4):497-504. PubMed ID: 2890093
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of human platelet guanylate cyclase by fatty acids.
Glass DB; Frey W; Carr DW; Goldberg ND
J Biol Chem; 1977 Feb; 252(4):1279-85. PubMed ID: 14150
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation and cyclic nucleotide phosphodiesterase activity in arteriosclerotic patients.
Yamazaki H; Motomiya T; Mashimo N; Asano T; Hidaka H
Thromb Haemost; 1978 Feb; 39(1):158-66. PubMed ID: 205971
[TBL] [Abstract][Full Text] [Related]
17. Coordinate interactions of cyclic nucleotide and phospholipid metabolizing pathways in calcium-dependent cellular processes.
Laychock SG
Curr Top Cell Regul; 1989; 30():203-42. PubMed ID: 2559830
[TBL] [Abstract][Full Text] [Related]
18. Correlation between adenosine 3',5'-cyclic monosphosphate levels, adenylate cyclase activity, and adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in tissue culture cells stimulated by serum.
Matsumoto T; Uchida T
J Biochem; 1975 Oct; 78(4):811-5. PubMed ID: 175046
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
Hagiwara M; Endo T; Kanayama T; Hidaka H
J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
[TBL] [Abstract][Full Text] [Related]
20. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
